J Intern Med. 2009 Nov;266(5):432-44. Epub 2009 Aug 21.

Vaccinate your child and save its grandparents from a heart attack? Current perspectives in antipneumococcal vaccination.

Source

Department of Public Health, Primary Care Service of Tarragona-Valls, Institut Català de la Salut, Tarragona, Spain. avila.tarte.ics@gencat.cat

Abstract

Streptococcus pneumoniae is an important cause of morbidity and mortality worldwide. There are three established approaches to anti-pneumococcal vaccination: capsular polysaccharide pneumococcal vaccine (PPV), protein-polysaccharide conjugate pneumococcal vaccine (CPV) and protein-based pneumococcal vaccine (PBPV). At present, only a 23-valent PPV for use in adults and a seven-valent CPV for use in infants are available in clinical practice. This study reviews available data on the efficacy of the available vaccines in different age groups and disease presentations, and the advantages and shortcomings of each type of vaccine, including future perspectives. Special attention is given to controversies regarding the efficacy of PPV against pneumonia in adults and its protective effects against myocardial infarction.

PMID:: 19754854; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Supplemental Content

Save items

Related citations in PubMed

Review Advances in pneumococcal vaccines: what are the advantages for the elderly? [Drugs Aging. 2007]
Review Advances in pneumococcal vaccines: what are the advantages for the elderly?
Vila-Córcoles A. Drugs Aging. 2007; 24(10):791-800.
Review Pneumococcal polysaccharide protein D-conjugate vaccine (Synflorix; PHiD-CV). [Paediatr Drugs. 2009]
Review Pneumococcal polysaccharide protein D-conjugate vaccine (Synflorix; PHiD-CV).
Croxtall JD, Keating GM. Paediatr Drugs. 2009; 11(5):349-57.
Review [Two pneumococcal vaccines: the 7-valent conjugate vaccine (Prevenar) for children up to the age of 5 years and the 23-valent polysaccharide vaccine (Pneumo 23) for the elderly and specific groups at risk]. [Ned Tijdschr Geneeskd. 2007]
Review [Two pneumococcal vaccines: the 7-valent conjugate vaccine (Prevenar) for children up to the age of 5 years and the 23-valent polysaccharide vaccine (Pneumo 23) for the elderly and specific groups at risk].
de Greeff SC, Sanders EA, de Melker HE, van der Ende A, Vermeer PE, Schouls LM. Ned Tijdschr Geneeskd. 2007 Jun 30; 151(26):1454-7.
Comparing potential benefits of new pneumococcal vaccines with the current polysaccharide vaccine in the elderly. [Vaccine. 2002]
Comparing potential benefits of new pneumococcal vaccines with the current polysaccharide vaccine in the elderly.
Fry AM, Zell ER, Schuchat A, Butler JC, Whitney CG. Vaccine. 2002 Dec 13; 21(3-4):303-11.
Conjugate pneumococcal vaccine in HIV-infected Ugandans and the effect of past receipt of polysaccharide vaccine. [J Infect Dis. 2005]
Conjugate pneumococcal vaccine in HIV-infected Ugandans and the effect of past receipt of polysaccharide vaccine.
Miiro G, Kayhty H, Watera C, Tolmie H, Whitworth JA, Gilks CF, French N. J Infect Dis. 2005 Nov 15; 192(10):1801-5. Epub 2005 Oct 5.

See reviews... See all...

Cited by 1 PubMed Central article

Rationale and design of the CAPAMIS study: effectiveness of pneumococcal vaccination against community-acquired pneumonia, acute myocardial infarction and stroke. [BMC Public Health. 2010]
Rationale and design of the CAPAMIS study: effectiveness of pneumococcal vaccination against community-acquired pneumonia, acute myocardial infarction and stroke.
Vila-Corcoles A, Hospital-Guardiola I, Ochoa-Gondar O, de Diego C, Salsench E, Raga X, Fuentes-Bellido CM. BMC Public Health. 2010 Jan 19; 10:25. Epub 2010 Jan 19.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Vaccinate your child and save its grandparents from a heart attack? Current pers...
Vaccinate your child and save its grandparents from a heart attack? Current perspectives in antipneumococcal vaccination.
J Intern Med. 2009 Nov ;266(5):432-44. Epub 2009 Aug 21 .

PubMed
Alpha 1-antitrypsin Null(isola di procida): an alpha 1-antitrypsin deficiency al...
Alpha 1-antitrypsin Null(isola di procida): an alpha 1-antitrypsin deficiency allele caused by deletion of all alpha 1-antitrypsin coding exons.
Am J Hum Genet. 1990 Sep ;47(3):403-13.

PubMed
A putative hexamerin from a Campodea sp. suggests an independent origin of haemo...
A putative hexamerin from a Campodea sp. suggests an independent origin of haemocyanin-related storage proteins in Hexapoda.
Insect Mol Biol. 2009 Oct ;18(5):673-9.

PubMed
A review of high-pressure freezing preparation techniques for correlative light ...
A review of high-pressure freezing preparation techniques for correlative light and electron microscopy of the same cells and tissues.
J Microsc. 2009 Sep ;235(3):273-81.

PubMed
Bridge to heart transplantation with left ventricular assist device versus inotr...
Bridge to heart transplantation with left ventricular assist device versus inotropic agents in status 1 patients.
J Card Surg. 2009 Nov-Dec ;24(6):756-62. Epub 2009 Sep 14 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: